“Review of new biological drugs and JAK inhibitors approved for children and adolescents with moderate to severe atopic dermatitis: the situation in Uruguay” (2026) Archives of Pediatrics of Uruguay, 97(1), p. e801. doi:10.31134/AP.97.1.20.